Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031220108Completed
Open-label, single-arm trial of ceftriaxone, sponsored by University of Tsukuba Hospital. Primary endpoint: CSF/blood concentration ratio of ceftriaxone on day 1. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031220108.